Exact Launches Real-World Trial Of Cologuard Colon Cancer Screening

Exact Sciences Corp. and the Mayo Clinic are launching a 150,000-patient clinical trial examining the real-world effects of colorectal cancer screening with the Cologuard colon cancer test.

The concept of business, technology, the Internet and the network. A young businessman collects a puzzle with the proper inscription: Clinical trial - Image

A new study will assess the real-world impact of the Cologuard colon cancer test on colon cancer treatment over the course of seven years.

The Voyage study, sponsored by test manufacturers Exact Sciences Corp. and the Mayo Clinic, will follow clinical outcomes in at least 150,000 people with a valid Cologuard order...

More from Clinical Trials

More from R&D